Clinical and pharmacological effects of monoamine precursors or haloperidol in chronic schizophrenia.
D006916:5-Hydroxytryptophan / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D012559:Schizophrenia / Q000188:drug therapy*
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan; D006220:Haloperidol